Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Indoleamine 2,3-dioxygenase (IDO) is induced by proinflammatory cytokines and by CTLA-4-expressing T cells and constitutes an important mediator of peripheral immune tolerance. In chronic hepatitis C, we found upregulation of IDO expression in the liver and an increased serum kynurenine/tryptophan r...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	Larrea, E, Riezu-Boj, J, Gil-Guerrero, L, Casares, N, Aldabe, R, Sarobe, P, Civeira, M, Heeney, J, Rollier, C, Verstrepen, B, Wakita, T, Borrás-Cuesta, F, Lasarte, J, Prieto, J
Format:	Journal article
Sprache:	English
Veröffentlicht:	2007

Ähnliche Einträge

Indoleamine 2,3-dioxygenase in endometriosis
von: Hui-Li Yang, et al.
Veröffentlicht: (2019-01-01)

Rational design of indoleamine 2,3-dioxygenase inhibitors.
von: Röhrig, U, et al.
Veröffentlicht: (2010)

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration.
von: Chun-Sing Lam, et al.
Veröffentlicht: (2017-01-01)

Role of indoleamine 2,3-dioxygenase in pathology of the gastrointestinal tract
von: Aleksandar Acovic, et al.
Veröffentlicht: (2018-12-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
von: Andrew L. Mellor, et al.
Veröffentlicht: (2017-10-01)

Galectin-1 induces a tumor-associated macrophage phenotype and upregulates indoleamine 2,3-dioxygenase-1
von: Asha M. Rudjord-Levann, et al.
Veröffentlicht: (2023-07-01)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges.
von: Quan, J, et al.
Veröffentlicht: (2008)

Manipulation of indoleamine 2,3-dioxygenase (IDO) for clinical transplantation: promises and challenges
von: Quan, J, et al.
Veröffentlicht: (2008)

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.
von: Kudo, Y, et al.
Veröffentlicht: (2004)

Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia.
von: Kudo, Y, et al.
Veröffentlicht: (2003)

Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.
von: Orabona, C, et al.
Veröffentlicht: (2018)

The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
von: Chiara Suvieri, et al.
Veröffentlicht: (2024-11-01)

Research progress of indoleamine 2,3-dioxygenase 1 in gastric cancer
von: Pei Xiaxia, et al.
Veröffentlicht: (2023-03-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
von: Camilla Grønkjær Jensen, et al.
Veröffentlicht: (2021-07-01)

Indoleamine 2,3- Dioxygenase: A Novel Immunotherapeutic Target for Osteosarcoma
von: Asim Farooq, et al.
Veröffentlicht: (2022-09-01)

Comprehensive behavioral analysis of indoleamine 2,3‐dioxygenase knockout mice
von: Nao Hirata, et al.
Veröffentlicht: (2018-09-01)

The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
von: Yuhei Shibata, et al.
Veröffentlicht: (2016-01-01)

The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer
von: Ding Ya, et al.
Veröffentlicht: (2009-08-01)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
von: Tao Zhang, et al.
Veröffentlicht: (2017-01-01)

IL-32 induces indoleamine 2,3-dioxygenase+CD1c+ dendritic cells and indoleamine 2,3-dioxygenase+CD163+ macrophages: Relevance to mycosis fungoides progression
von: Hanako Ohmatsu, et al.
Veröffentlicht: (2017-02-01)

Indoleamine 2,3 dioxygenase activity aggravates the course and pathology of murine tuberculosis
von: Guo, L, et al.
Veröffentlicht: (2018)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
von: V. A. Kozlov, et al.
Veröffentlicht: (2017-07-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
von: Cemil Bilir, M.D., et al.
Veröffentlicht: (2017-07-01)

Serum indoleamine 2,3-dioxygenase level and diagnostic value in patients with rosacea
von: Merve Sena Odabasi, et al.
Veröffentlicht: (2023-01-01)

Tolerance induction by monoclonal CD3 antibodies is dependent on indoleamine 2,3 dioxygenase (IDO)
von: Kuhn, C, et al.
Veröffentlicht: (2012)

Forty‐three key gene expressions involved in the effect of indoleamine 2,3‐dioxygenase 1 expression on cancer prognosis may be a potential indoleamine 2,3‐dioxygenase 1 inhibitor biomarker
von: Weirui Li, et al.
Veröffentlicht: (2021-02-01)

Modulation of indoleamine 2,3-dioxygenase by interferon-gamma in human placental chorionic villi.
von: Kudo, Y, et al.
Veröffentlicht: (2000)

Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation.
von: Kudo, Y, et al.
Veröffentlicht: (2001)

Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma
von: Heike Loeser, et al.
Veröffentlicht: (2020-01-01)

Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study
von: Binbin Pan, et al.
Veröffentlicht: (2021-01-01)

Evaluation of mode of indoleamine 2,3-dioxygenase 1 inhibition by 4,7-dichloroquinolines
von: Niku Moni Das, et al.
Veröffentlicht: (2023-12-01)

Regulation of the Immune Checkpoint Indoleamine 2,3-Dioxygenase Expression by Epstein–Barr Virus
von: Leila Sawada, et al.
Veröffentlicht: (2021-11-01)

Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression
von: Karl Savonije, et al.
Veröffentlicht: (2023-05-01)

Significance of Indoleamine 2,3-Dioxygenase Expression in the Immunological Response of Kidney Graft Recipients
von: Krzysztof Wiśnicki, et al.
Veröffentlicht: (2022-09-01)

The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression
von: Hengshu Chen, et al.
Veröffentlicht: (2023-02-01)

Identification of Genetic Markers Linked to The Activity of Indoleamine 2,3-Dioxygenase and Kidney Function
von: Hye-Rim Kim, et al.
Veröffentlicht: (2023-04-01)

Laeverin/aminopeptidase Q induces indoleamine 2,3-dioxygenase-1 in human monocytes
von: Takuma Suzuki, et al.
Veröffentlicht: (2023-09-01)

Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts
von: Ong Christopher, et al.
Veröffentlicht: (2010-01-01)

The role of indoleamine 2,3-dioxygenase (IDO) in the pathogenesis of non-alcoholic steatohepatitis (NASH) and atherosclerosis as comorbidities
von: Arora, A, et al.
Veröffentlicht: (2021)

Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges
von: Peng X, et al.
Veröffentlicht: (2022-08-01)